June 09, 2025

Does Autism Increase Parkinson Risk?

A cohort study of more than 2 million individuals found that autism spectrum disorder was associated with a more than fourfold increased risk of Parkinson disease before age 50 years, even after adjusting for psychiatric medication use and depression.

Conexiant

June 03, 2025

Stopping Antipsychotics May Lower Risks Posthospitalization: Study

Older adults who stopped antipsychotic medications after hospitalization had fewer rehospitalizations, less delirium, and lower mortality, according to a large U.S. study using real-world Medicare data.

Conexiant

June 02, 2025

Kids, Interrupted: America’s Youngest Caregivers

Millions of children are caring for sick or disabled adults at home — a growing crisis fueled by shrinking Medicaid funds and fading support systems.

KFF Health News

May 28, 2025

Kennedy Proposes NIH Publishing Ban

"We're probably going to stop publishing in The Lancet, New England Journal of Medicine, JAMA, and those other journals because they're all corrupt."

Conexiant

May 28, 2025

FDA Clears AI Upgrade for Portable MRI

Optive AI software enhances image quality for the Swoop system.

Conexiant

May 09, 2024

Time of Day May Impact Aging Predictions

New study reveals that epigenetic age predictions fluctuate significantly throughout the day, emphasizing the need to consider timing in aging assessments.

Conexiant

July 26, 2024

Healing and Owing: U.S. Health Workers' $150 Billion Debt Dilemma

A new study exposes the alarming levels of medical and educational debt burdening U.S. health care workers, with debt disproportionately affecting women, Black workers, and those in lower-paying fields.

Conexiant

January 15, 2025

Bertagnolli to Exit NIH Director Role

NIH director, Dr. Monica M. Bertagnolli, is stepping down after launching major initiatives in women's health and long COVID research, indicating optimism for their continuation under new leadership.

Conexiant

September 30, 2024

Can L-DOPA Protect Against nAMD?

Patients consistently treated with L-DOPA also had lower progression rates from intermediate AMD to nAMD compared to non-treated groups.

Conexiant